FDA Inspection 988784 — Wyeth BioPharma Division Of Wyeth Pharmaceuticals LLC

Wyeth BioPharma Division Of Wyeth Pharmaceuticals LLC — FEI 1222181

The FDA completed an inspection of Wyeth BioPharma Division Of Wyeth Pharmaceuticals LLC on Sep 30, 2016 in Andover, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 30, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Andover, MA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.